J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 507, Number 3, 679-687, March 15, 1998
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farkas, I.
Right arrow Articles by Okada, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farkas, I.
Right arrow Articles by Okada, H.
The Journal of Physiology (1998), 507.3, pp. 679-687
© Copyright 1998 The Physiological Society

A neuronal C5a receptor and an associated apoptotic signal transduction pathway

I. Farkas *, L. Baranyi ¹, M. Takahashi ¹, A. Fukuda ², Zs. Liposits ³, T. Yamamoto ¹ and H. Okada *

* Department of Molecular Biology, Nagoya City University School of Medicine, Nagoya 467, ¹ Choju Medical Institute, Fukushimura Hospital, Toyohashi 441, ² Department of Physiology, Nagoya City University School of Medicine, Nagoya 467, Japan and ³ Department of Anatomy, Albert Szent-Györgyi Medical University, 6724 Szeged, Hungary

  1. We report the first experimental evidence of a neuronal C5a receptor (nC5aR) in human cells of neuronal origin. Expression of nC5aR mRNA was demonstrated by the reverse transcriptase-polymerase chain reaction (RT-PCR) in TGW human neuroblastoma cells.

  2. Expression of a functional C5aR was supported by the finding that C5a evoked a transient increase in the intracellular calcium level as measured by flow cytometry (FACS).

  3. To analyse the function of the nC5aR, an antisense peptide fragment of the C5aR was used. Previous data showed that a C5aR fragment (a peptide termed PR226) has C5aR agonist and antagonist effects in U-937 cells depending on the concentration of the peptide. We found that a multiple antigenic peptide (MAP) form of the same peptide (termed PR226-MAP) induced rapid elevation of nuclear c-fos immunoreactivity and resulted in DNA fragmentation, a characteristic sign of apoptosis, in TGW cells.

  4. Early electrophysiological events characteristic of apoptosis were also detected: intermittent calcium current pulses were recorded within 1-2 min of peptide administration. C5a pretreatment delayed the onset of this calcium influx.

  5. We also demonstrated that the apoptotic pathway is linked to nC5aR via pertussis toxin-sensitive G-proteins.

  6. Although the function of C5a and its receptor on neurons is unknown, these results suggest that an abnormal activation of this signal transduction pathway can result in apoptosis and, subsequently, in neurodegeneration.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Daveau, M. Benard, M. Scotte, M.-T. Schouft, M. Hiron, A. Francois, J.-P. Salier, and M. Fontaine
Expression of a Functional C5a Receptor in Regenerating Hepatocytes and Its Involvement in a Proliferative Signaling Pathway in Rat
J. Immunol., September 1, 2004; 173(5): 3418 - 3424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Do, R. J. McKallip, M. Nagarkatti, and P. S. Nagarkatti
Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-{kappa}B-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation
J. Immunol., August 15, 2004; 173(4): 2373 - 2382.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Farkas, M. Takahashi, A. Fukuda, N. Yamamoto, H. Akatsu, L. Baranyi, H. Tateyama, T. Yamamoto, N. Okada, and H. Okada
Complement C5a Receptor-Mediated Signaling May Be Involved in Neurodegeneration in Alzheimer's Disease
J. Immunol., June 1, 2003; 170(11): 5764 - 5771.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Kimura, M. Madhavan, M. K. Call, W. Santiago, P. A. Tsonis, J. D. Lambris, and K. Del Rio-Tsonis
Expression of Complement 3 and Complement 5 in Newt Limb and Lens Regeneration
J. Immunol., March 1, 2003; 170(5): 2331 - 2339.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. O'Barr, J. Caguioa, D. Gruol, G. Perkins, J. A. Ember, T. Hugli, and N. R. Cooper
Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment
J. Immunol., March 15, 2001; 166(6): 4154 - 4162.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H. P. Jia, P. B. McCray Jr., B. F. Tack, and R. A. Wetsel
Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma
J. Immunol., February 1, 2001; 166(3): 2025 - 2032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 The Physiological Society.